Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TITAN trial of induction TPF therapy in advanced head and neck cancer
ISRCTN74465582Phase 3Completed
- Sponsor
- Aintree University Hospital
- Start
- Sep 2011
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, open-label trial of docetaxel, cisplatin and fluorouracil in head and neck squamous cell carcinoma (HNSCC) (2 arms), sponsored by Aintree University Hospital. Primary endpoint: Feasibility of recruitment into the TITAN trial. Started Sep 2011; status: completed.
02
Drugs
docetaxelcisplatinfluorouracil
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on ISRCTN74465582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN74465582.